RNASE3 and asthma: Similar trends were observed for sputum ECP, i.e. median (range) levels before and after AMP were 16.0 (2.5 - 170.0) and 14.8 (2.6 - 63.7), respectively, in the group with complete asthma remission and 36.3 (6.0 - 2467.0) and 47.3 (9.0 - 1628.0) in the group with current asthma.